RAPIZZI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 3.023
EU - Europa 1.721
AS - Asia 550
AF - Africa 17
OC - Oceania 1
SA - Sud America 1
Totale 5.313
Nazione #
US - Stati Uniti d'America 3.015
RU - Federazione Russa 405
PL - Polonia 354
IT - Italia 279
IE - Irlanda 240
SE - Svezia 217
HK - Hong Kong 162
SG - Singapore 145
CN - Cina 118
FI - Finlandia 59
IN - India 45
JO - Giordania 44
DE - Germania 39
GB - Regno Unito 38
UA - Ucraina 32
CH - Svizzera 27
KR - Corea 14
CI - Costa d'Avorio 13
BE - Belgio 12
VN - Vietnam 12
NL - Olanda 9
TR - Turchia 9
CA - Canada 8
FR - Francia 5
ZA - Sudafrica 4
ES - Italia 3
AU - Australia 1
CL - Cile 1
KG - Kirghizistan 1
RO - Romania 1
RS - Serbia 1
Totale 5.313
Città #
Fairfield 533
Warsaw 352
Ashburn 278
Woodbridge 255
Dublin 240
Chandler 225
Cambridge 207
Seattle 194
Wilmington 178
Houston 175
Singapore 119
Hong Kong 115
Ann Arbor 108
Altamura 98
Lawrence 98
Florence 71
Princeton 64
Beijing 63
Jacksonville 52
Mumbai 39
Boston 38
Moscow 35
Boardman 34
Buffalo 33
Medford 33
San Diego 28
Bern 25
Shanghai 25
New York 20
Santa Clara 20
Helsinki 16
Abidjan 13
Kent 13
Seoul 13
Milan 12
West Jordan 12
Brussels 11
Falls Church 11
Hillsboro 11
Dong Ket 10
Norwalk 10
Los Angeles 9
Redmond 8
Redwood City 8
Haarlem 7
Izmir 7
Rome 6
Prato 5
Toronto 5
Cape Town 4
Lappeenranta 4
London 4
Pune 4
Romainville 4
Auburn Hills 3
Barcelona 3
Bologna 3
Bremen 3
Fontebuona 3
Guangzhou 3
Leawood 3
Old Bridge 3
Ottawa 3
Phoenix 3
Verona 3
Andover 2
Ankara 2
Ansbach 2
Biloxi 2
Borgo San Giacomo 2
Cagliari 2
Catania 2
Chieri 2
Chiswick 2
Frankfurt am Main 2
Impruneta 2
Krefeld 2
Laurel 2
Melito Di Napoli 2
Radomsko 2
San Giovanni Valdarno 2
Schweinfurt 2
Tappahannock 2
Volketswil / Volketswil (Dorf) 2
Wuhan 2
Xi'an 2
Arezzo 1
Bangalore 1
Bari 1
Bishkek 1
Brindisi 1
Calenzano 1
Casapulla 1
Chicago 1
Concepción 1
Dongguan 1
Frankfurt Am Main 1
Fucecchio 1
Gonnoscodina 1
Gwangjin-gu 1
Totale 4.051
Nome #
Updated and new perspectives on diagnosis, prognosis, and therapy of malignant pheochromocytoma/paraganglioma. 215
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 206
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 162
Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomas. 154
Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer 144
miR-210-3p mediates metabolic adaptation and sustains DNA damage repair of resistant colon cancer cells to treatment with 5-fluorouracil 141
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 126
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 123
Epigenetic Mutation of the Succinate Dehydrogenase C Promoter in a Patient With Two Paragangliomas. 114
Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription 109
ED2+ macrophages increase selectively myoblast proliferation in muscle cultures. 109
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 103
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 98
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 97
The Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. 97
A unique neuroendocrine cell model derived from the human foetal neural crest. 97
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 96
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 95
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency. 95
Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. 92
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 90
Sphingosine 1-phosphate differentially regulates proliferation of C2C12 reserve cells and myoblasts 88
Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts 86
INHIBITION OF POLY(ADP-RIBOSE) GLYCOHYDROLASE BY GALLOTANNIN SELECTIVELY UP-REGULATES EXPRESSION OF PRO-INFLAMMATORY GENES. 86
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 85
Poly(ADP-ribose) catabolism triggers AMP-dependent mitochondrial energy failure 84
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 81
Antiphospholipid antibody syndrome and polymyalgia rheumatica/giant cell arteritis. 80
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 79
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 78
Sphingosine 1-phosphate receptors modulate intracellular Ca2+ homeostasis 78
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 77
Human satellite cell proliferation in vitro is regulated by autocrine secretion of IL-6 stimulated by a soluble factor(s) released by activated monocytes. 76
Correction for age of anticardiolipin antibodies cut-off points. 76
Tumor necrosis factor-α exerts promyogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling. 75
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 69
Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. 67
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 67
Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. 65
Recombinant aequorin and green fluorescent protein as valuable tools in the study of cell signalling. 64
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 60
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 60
Pheochromocytoma/paraganglioma preclinical models: which to use and why? 57
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 57
Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells 55
Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool 54
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 54
Sphingosine 1-phosphate increases glucose uptake through trans-activation of insulin receptor. 53
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients 53
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation. 52
SDHB and SDHD silenced pheochromocytoma spheroids respond differently to tumour microenvironment and their aggressiveness is inhibited by impairing stroma metabolism 52
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 50
A role for calcium in Bcl-2 action? 46
Early derangement of axonal mitochondria occurs in a mouse model of progressive but not relapsing-remitting multiple sclerosis 45
Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics 45
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 45
Outcome of fifty-five newborns of antiphospholipid antibody-positive mothers treated with calcium heparin during pregnancy. 43
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas 41
Functional significance of germline EPAS1 variants 41
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 41
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 39
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 39
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma 36
Metformin Treatment Induces Different Response in Pheochromocytoma/Paraganglioma Tumour Cells and in Primary Fibroblasts 36
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 30
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 30
Tumour microenvironment in pheochromocytoma and paraganglioma 29
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 28
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina 27
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 24
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 22
Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas 22
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 20
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 3
Totale 5.413
Categoria #
all - tutte 18.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.277


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020912 0 0 46 83 113 113 124 117 115 82 98 21
2020/2021711 60 53 53 62 22 114 35 44 67 114 41 46
2021/2022479 14 47 57 16 17 27 18 47 11 30 70 125
2022/20231.196 96 280 54 73 74 185 148 49 134 26 45 32
2023/2024577 14 54 76 36 45 66 19 135 30 42 44 16
2024/2025677 104 368 205 0 0 0 0 0 0 0 0 0
Totale 5.413